Fulgent Genetics, Inc.
US ˙ NasdaqGM ˙ US3596641098

Introduction

This page provides a comprehensive analysis of the known insider trading history of John C Bolger. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate John C Bolger has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:FLGT / Fulgent Genetics, Inc. Director 5,100
US:TNTR / Tintri, Inc. Director 8,332
US:IDTI / Integrated Device Technology, Inc. Director 11,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John C Bolger. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases FLGT / Fulgent Genetics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in FLGT / Fulgent Genetics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FLGT / Fulgent Genetics, Inc. Insider Trades
Insider Sales FLGT / Fulgent Genetics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in FLGT / Fulgent Genetics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2022-05-31 FLGT BOLGER JOHN C 313 55.3200 313 55.3200 17,315 338 28.5200 -8,388 -48.44
2022-05-31 FLGT BOLGER JOHN C 313 55.4352 313 55.4352 17,351
2022-05-31 FLGT BOLGER JOHN C 500 55.2500 500 55.2500 27,625
2022-03-01 FLGT BOLGER JOHN C 625 61.4202 625 61.4202 38,388
2022-03-01 FLGT BOLGER JOHN C 625 61.4020 625 61.4020 38,376
2022-03-01 FLGT BOLGER JOHN C 625 61.2681 625 61.2681 38,293
2021-08-30 FLGT BOLGER JOHN C 312 91.3806 312 91.3806 28,511
2021-08-30 FLGT BOLGER JOHN C 312 91.0540 312 91.0540 28,409
2021-08-30 FLGT BOLGER JOHN C 312 91.4420 312 91.4420 28,530
2021-06-03 FLGT BOLGER JOHN C 125 74.1700 125 74.1700 9,271
2021-06-01 FLGT BOLGER JOHN C 1,876 71.4102 1,876 71.4102 133,966
2021-03-09 FLGT BOLGER JOHN C 3,374 101.6248 3,374 101.6248 342,882
2020-11-17 FLGT BOLGER JOHN C 4,269 44.2438 4,269 44.2438 188,877
2020-08-17 FLGT BOLGER JOHN C 3,914 40.8705 3,914 40.8705 159,967
2020-05-22 FLGT BOLGER JOHN C 8,677 15.3611 8,677 15.3611 133,288

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

FLGT / Fulgent Genetics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by John C Bolger as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-08-03 2022-08-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
A - Award 1,600 5,100 45.71
2022-06-02 2022-05-31 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -500 3,500 -12.50 55.25 -27,625 193,375
2022-06-02 2022-05-31 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -313 4,000 -7.26 55.44 -17,351 221,741
2022-06-02 2022-05-31 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 313 4,313 7.82 5.81 1,818 25,058
2022-06-02 2022-05-31 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -313 4,000 -7.26 55.32 -17,315 221,280
2022-06-02 2022-05-31 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 313 4,313 7.82 3.92 1,229 16,929
2022-05-20 2022-05-18 4 FLGT Fulgent Genetics, Inc.
Common Stock
A - Award 2,000 4,000 100.00
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -625 2,813 -18.18
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -625 2,813 -18.18
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -625 1,563 -28.56
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -625 2,000 -23.81 61.27 -38,293 122,536
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 625 2,625 31.25 15.82 9,888 41,528
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -625 2,000 -23.81 61.40 -38,376 122,804
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 625 2,625 31.25 5.81 3,631 15,251
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -625 2,000 -23.81 61.42 -38,388 122,840
2022-03-03 2022-03-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 625 2,625 31.25 3.92 2,453 10,303
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -312 3,438 -8.32
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -312 3,438 -8.32
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -312 2,188 -12.48
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -312 2,000 -13.49 91.44 -28,530 182,884
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 312 2,312 15.60 5.81 1,813 13,432
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -312 2,000 -13.49 91.05 -28,409 182,108
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 312 2,312 15.60 15.82 4,936 36,576
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -312 2,000 -13.49 91.38 -28,511 182,761
2021-09-01 2021-08-30 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 312 2,312 15.60 3.92 1,225 9,075
2021-06-07 2021-06-03 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -125 2,000 -5.88 74.17 -9,271 148,340
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -1,250 3,750 -25.00
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -313 2,500 -11.13
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -313 1,250 -20.03
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -1,876 2,125 -46.89 71.41 -133,966 151,747
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 1,250 4,001 45.44 15.82 19,775 63,296
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 313 2,751 12.84 5.81 1,819 15,983
2021-06-03 2021-06-01 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 313 2,438 14.73 3.93 1,230 9,581
2021-05-24 2021-05-20 4 FLGT Fulgent Genetics, Inc.
Common Stock
A - Award 2,000 2,125 1,600.00
2021-03-11 2021-03-09 4 FLGT Fulgent Genetics, Inc.
Stock Options (Right to Buy)
M - Exercise -2,187 2,813 -43.74
2021-03-11 2021-03-09 4 FLGT Fulgent Genetics, Inc.
Stock Options (Right to Buy)
M - Exercise -937 1,563 -37.48
2021-03-11 2021-03-09 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -3,374 125 -96.43 101.62 -342,882 12,703
2021-03-11 2021-03-09 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 2,187 3,499 166.69 5.81 12,706 20,328
2021-03-11 2021-03-09 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 937 1,312 249.87 3.92 3,678 5,150
2020-11-18 2020-11-17 4 FLGT Fulgent Genetics, Inc.
Stock Options (Right to Buy)
M - Exercise -2,631 0 -100.00
2020-11-18 2020-11-17 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -4,269 375 -91.93 44.24 -188,877 16,591
2020-11-18 2020-11-17 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 2,631 4,644 130.70 0.38 1,000 1,765
2020-08-19 2020-08-17 4 FLGT Fulgent Genetics, Inc.
Stock Options (Right to Buy)
M - Exercise -2,631 0 -100.00
2020-08-19 2020-08-17 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -3,914 2,013 -66.04 40.87 -159,967 82,272
2020-08-19 2020-08-17 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 2,631 5,927 79.82 12.31 32,393 72,973
2020-05-27 2020-05-27 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
A - Award 5,000 5,000
2020-05-27 2020-05-22 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -2,631 0 -100.00
2020-05-27 2020-05-22 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
M - Exercise -2,500 2,500 -50.00
2020-05-27 2020-05-22 4 FLGT Fulgent Genetics, Inc.
Common Stock
S - Sale -8,677 3,296 -72.47 15.36 -133,288 50,630
2020-05-27 2020-05-22 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 2,631 11,973 28.16 0.38 1,000 4,550
2020-05-27 2020-05-22 4 FLGT Fulgent Genetics, Inc.
Common Stock
M - Exercise 2,500 9,342 36.54 3.92 9,812 36,667
2019-06-03 2019-05-30 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
A - Award 5,000 5,000
2018-05-21 2018-05-18 4 FLGT Fulgent Genetics, Inc.
Stock Option (Right to Buy)
A - Award 5,000 5,000
2017-06-29 3 TNTR Tintri, Inc.
Common Stock
8,332
2017-06-29 3 TNTR Tintri, Inc.
Common Stock
8,332
2017-06-12 2017-05-16 4/A FLGT Fulgent Genetics, Inc.
Common Stock
A - Award 2,000 6,842 41.31
2016-10-28 2016-10-26 4 FLGT Fulgent Genetics, Inc.
Common Stock
A - Award 4,842 4,842
2016-10-04 2016-09-30 4 FLGT Fulgent Genetics, Inc.
Issuer Stock Option (Right to Buy)
A - Award 2,631 2,631
2016-10-04 2016-09-30 4 FLGT Fulgent Genetics, Inc.
Issuer Stock Option (Right to Buy)
A - Award 2,631 2,631
2016-10-04 2016-09-30 4 FLGT Fulgent Genetics, Inc.
Issuer Stock Option (Right to Buy)
A - Award 2,631 2,631
2016-10-04 2016-09-30 4 FLGT Fulgent Genetics, Inc.
Predecessor Unit Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2016-10-04 2016-09-30 4 FLGT Fulgent Genetics, Inc.
Predecessor Unit Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2016-10-04 2016-09-30 4 FLGT Fulgent Genetics, Inc.
Predecessor Unit Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2016-10-04 2016-06-22 4 FLGT Fulgent Genetics, Inc.
Predecessor Unit Option (Right to Buy)
A - Award 20,000 20,000
2016-10-04 2016-04-13 4 FLGT Fulgent Genetics, Inc.
Predecessor Unit Option (Right to Buy)
A - Award 20,000 20,000
2005-09-16 2005-09-15 4 IDTI INTEGRATED DEVICE TECHNOLOGY INC
Non-Qualified Stock Option (right to buy)
A - Award 1,000 11,000 10.00
2005-09-16 2005-09-15 4 IDTI INTEGRATED DEVICE TECHNOLOGY INC
Non-Qualified Stock Option (right to buy)
A - Award 10,000 10,000
2004-09-20 2004-09-16 4 IDTI INTEGRATED DEVICE TECHNOLOGY INC
Non-Qualified Stock Option (right to buy)
A - Award 1,000 11,000 10.00
2004-09-20 2004-09-16 4 IDTI INTEGRATED DEVICE TECHNOLOGY INC
Non-Qualified Stock Option (right to buy)
A - Award 10,000 10,000
2003-09-15 2003-09-12 4 IDTI INTEGRATED DEVICE TECHNOLOGY INC
Non-Qualified Stock Option (right to buy)
A - Award 1,000 11,000 10.00
2003-09-15 2003-09-12 4 IDTI INTEGRATED DEVICE TECHNOLOGY INC
Non-Qualified Stock Option (right to buy)
A - Award 10,000 10,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)